This is a snippet of the transcript, sign up to read more.
I recall when TransDigm took over, there was a lot of talk about in other companies about economies of scale and leveraging the enterprise, among other buzzwords. However, these were almost considered taboo at TransDigm. While these concepts can work, they often come with bureaucratic bloat. TransDigm's focus is clear; price profitability and price productivity and profitable new sales. None of the other stuff plays. If you can’t show either hard savings in terms of real dollars or new business, it’s not real.
This is a snippet of the transcript, sign up to read more.
That's a great question, and I don't have a definitive answer. It's not just about the numbers. Many companies claim to be all about the numbers, but TransDigm is the first company I've worked at that truly operates in this way. All the metrics matter. For instance, there would be a president's letter every month that went to all the presidents, which required a significant effort to put together. So it was a lengthy document, maybe twelve pages, covering your operating division.
This is a snippet of the transcript, sign up to read more.
It was crucial to understand these market segments and accurately project sales for each. The significant difference between TransDigm and Korry Electronics was how we looked at sales. At Esterline, we focused on the projected sales in different market slices. However, TransDigm would look at the market volume based on the previous year's prices. For instance, if I sold 10 items for $100 each last year, that's $1,000. If I plan to sell ten more this year, that's another $1,000. But if I raise my prices by 5%, my sales are then calculated as market volume plus price. They implemented this method to gain a better understanding of margin changes.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research